In an exploration of 2 distinct timeframes in the 21st century, researchers examine the use and concurrent use of medication types among elderly US adults.
|Articles|July 15, 2022
News Roundup: July 11 to July 15
Author(s)Miranda Hester
Your weekly roundup of the latest news from Drug Topics®.
Advertisement
FDA Issues EUA for Novavax COVID-19 Vaccine, Adjuvanted
Adults aged 18 and older are eligible to receive the vaccine.
Helping Patients Manage Diabetes Burnout
Over time, the emotional burden of managing the disease can become overwhelming.
Prescription to OTC Switches A Boon for Pharmacy Front End
Medications that switch from prescription-only to OTC can be stocked in the pharmacy’s front end.
Specialty Drug Pipeline Updates for 2022
The specialty drug pipeline includes first- and next-in- class drugs across the oncology and immunology spaces.
Novel, Dual-Targeted Treatment for T2D Is FDA Approved
Tirzepatide is a once-weekly subcutaneous injection to treat type 2 diabetes in conjunction with diet and exercise.
Advertisement
Related to this article
The investigational anti–IL-33 antibody lowered exacerbation rates across all blood eosinophil levels, a benefit current COPD biologics do not offer.
This episode offers a detailed look into the FDA’s recent PCAC meeting and what the future of peptide compounding could lead to for pharmacy professionals.
A study finds children starting continuous glucose monitoring within a month of diagnosis sustained lower hemoglobin A1C than those who started later.
With obesity, muscle loss, and sleep disorders so prominent in postmenopause, providers are now looking into further expansion of GLP-1 use.
Menopause status and symptoms are inconsistently captured in electronic health records, leaving a gap in care for patients.
As midterm elections approach, the pharmacy industry is backing one of its most meaningful bills yet while the current congressional session wanes.
Data found reduced cardiovascular risk with hormone therapy, particularly among Black women and those starting treatment within 10 years of menopause.
Advertisement
Advertisement
Trending on Drug Topics
1
Tozorakimab Reduces COPD Exacerbations in Phase 3 Trials
2
Muscle Preservation Is Key in GLP-1 Therapy for Postmenopausal Women
3
Injectable HIV Treatment Beats Daily Pills in Adolescent Trial
4
FDA Approves Onswik Weekly Insulin for Adults With T2D
5